2 results
Approved WMOCompleted
The aim of this study is to assess for the first time in humans, the safety and feasibility of the EndoRotor® for the ablation of Barrett*s esophagus.
Approved WMOCompleted
The overall objective of the CAB LA + RPV LA clinical development programme is to develop a highly effective, well-tolerated, two-drug, long-acting injectable regimen which has the potential to offer improved treatment convenience, compliance and…